AdaptHealth (NASDAQ:AHCO) Price Target Raised to $14.00 at Canaccord Genuity Group

AdaptHealth (NASDAQ:AHCO - Free Report) had its price target boosted by Canaccord Genuity Group from $13.00 to $14.00 in a research report sent to investors on Wednesday,Benzinga reports. They currently have a buy rating on the stock.

Several other analysts have also recently commented on the stock. Royal Bank of Canada lifted their price objective on shares of AdaptHealth from $11.00 to $14.00 and gave the company an "outperform" rating in a research note on Wednesday. Truist Financial lifted their price objective on shares of AdaptHealth from $12.00 to $14.00 and gave the company a "buy" rating in a research note on Wednesday. Robert W. Baird decreased their price objective on shares of AdaptHealth from $16.00 to $14.00 and set an "outperform" rating for the company in a research note on Wednesday, November 6th. Finally, UBS Group decreased their price objective on shares of AdaptHealth from $12.00 to $11.00 and set a "buy" rating for the company in a research note on Thursday, February 13th. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat, AdaptHealth presently has an average rating of "Buy" and an average target price of $13.80.

AdaptHealth Stock Performance

NASDAQ AHCO traded up $0.29 on Wednesday, hitting $11.38. 1,758,793 shares of the company's stock traded hands, compared to its average volume of 1,097,015. The company has a current ratio of 1.24, a quick ratio of 1.00 and a debt-to-equity ratio of 1.34. AdaptHealth has a 1-year low of $8.35 and a 1-year high of $11.90. The firm's 50-day moving average price is $9.92 and its two-hundred day moving average price is $10.23. The firm has a market capitalization of $1.53 billion, a PE ratio of -6.90, a P/E/G ratio of 1.08 and a beta of 1.12.

Hedge Funds Weigh In On AdaptHealth

Large investors have recently made changes to their positions in the company. Assetmark Inc. acquired a new position in shares of AdaptHealth in the 4th quarter valued at $28,000. Blue Trust Inc. raised its position in AdaptHealth by 24.1% during the fourth quarter. Blue Trust Inc. now owns 5,746 shares of the company's stock worth $55,000 after acquiring an additional 1,115 shares during the period. Quarry LP raised its position in AdaptHealth by 4,596.9% during the third quarter. Quarry LP now owns 5,965 shares of the company's stock worth $67,000 after acquiring an additional 5,838 shares during the period. CIBC Asset Management Inc acquired a new position in AdaptHealth during the third quarter worth $122,000. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management raised its position in AdaptHealth by 15.4% during the fourth quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company's stock worth $121,000 after acquiring an additional 1,690 shares during the period. 82.67% of the stock is currently owned by institutional investors and hedge funds.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.